Interpretation of biomonitoring data in clinical medicine and the exposure sciences

Bryan L Williams, Dana B. Barr, J. Michael Wright, Brian Buckley, Melina S. Magsumbol

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Biomonitoring has become a fundamental tool in both exposure science and clinical medicine. Despite significant analytical advances, the clinical use of environmental biomarkers remains in its infancy. Clinical use of environmental biomarkers poses some complex scientific and ethical challenges. The purpose of this paper is compare how the clinical and exposure sciences differ with respect to their interpretation and use of biological data. Additionally, the clinical use of environmental biomonitoring data is discussed. A case study is used to illustrate the complexities of conducting biomonitoring research on highly vulnerable populations in a clinical setting.

Original languageEnglish (US)
Pages (from-to)76-80
Number of pages5
JournalToxicology and Applied Pharmacology
Volume233
Issue number1
DOIs
StatePublished - Nov 15 2008
Externally publishedYes

Fingerprint

Environmental Monitoring
Clinical Medicine
Biomarkers
Medicine
Vulnerable Populations
Research

Keywords

  • Biomarkers
  • Biomonitoring
  • Clinical medicine
  • Exposure science
  • Lead
  • Mercury
  • Neonatal exposures
  • Susceptible populations

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Interpretation of biomonitoring data in clinical medicine and the exposure sciences. / Williams, Bryan L; Barr, Dana B.; Wright, J. Michael; Buckley, Brian; Magsumbol, Melina S.

In: Toxicology and Applied Pharmacology, Vol. 233, No. 1, 15.11.2008, p. 76-80.

Research output: Contribution to journalArticle

Williams, Bryan L ; Barr, Dana B. ; Wright, J. Michael ; Buckley, Brian ; Magsumbol, Melina S. / Interpretation of biomonitoring data in clinical medicine and the exposure sciences. In: Toxicology and Applied Pharmacology. 2008 ; Vol. 233, No. 1. pp. 76-80.
@article{7ce4ba653069494cbb0d6c30aa4e4c8c,
title = "Interpretation of biomonitoring data in clinical medicine and the exposure sciences",
abstract = "Biomonitoring has become a fundamental tool in both exposure science and clinical medicine. Despite significant analytical advances, the clinical use of environmental biomarkers remains in its infancy. Clinical use of environmental biomarkers poses some complex scientific and ethical challenges. The purpose of this paper is compare how the clinical and exposure sciences differ with respect to their interpretation and use of biological data. Additionally, the clinical use of environmental biomonitoring data is discussed. A case study is used to illustrate the complexities of conducting biomonitoring research on highly vulnerable populations in a clinical setting.",
keywords = "Biomarkers, Biomonitoring, Clinical medicine, Exposure science, Lead, Mercury, Neonatal exposures, Susceptible populations",
author = "Williams, {Bryan L} and Barr, {Dana B.} and Wright, {J. Michael} and Brian Buckley and Magsumbol, {Melina S.}",
year = "2008",
month = "11",
day = "15",
doi = "10.1016/j.taap.2008.05.002",
language = "English (US)",
volume = "233",
pages = "76--80",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Interpretation of biomonitoring data in clinical medicine and the exposure sciences

AU - Williams, Bryan L

AU - Barr, Dana B.

AU - Wright, J. Michael

AU - Buckley, Brian

AU - Magsumbol, Melina S.

PY - 2008/11/15

Y1 - 2008/11/15

N2 - Biomonitoring has become a fundamental tool in both exposure science and clinical medicine. Despite significant analytical advances, the clinical use of environmental biomarkers remains in its infancy. Clinical use of environmental biomarkers poses some complex scientific and ethical challenges. The purpose of this paper is compare how the clinical and exposure sciences differ with respect to their interpretation and use of biological data. Additionally, the clinical use of environmental biomonitoring data is discussed. A case study is used to illustrate the complexities of conducting biomonitoring research on highly vulnerable populations in a clinical setting.

AB - Biomonitoring has become a fundamental tool in both exposure science and clinical medicine. Despite significant analytical advances, the clinical use of environmental biomarkers remains in its infancy. Clinical use of environmental biomarkers poses some complex scientific and ethical challenges. The purpose of this paper is compare how the clinical and exposure sciences differ with respect to their interpretation and use of biological data. Additionally, the clinical use of environmental biomonitoring data is discussed. A case study is used to illustrate the complexities of conducting biomonitoring research on highly vulnerable populations in a clinical setting.

KW - Biomarkers

KW - Biomonitoring

KW - Clinical medicine

KW - Exposure science

KW - Lead

KW - Mercury

KW - Neonatal exposures

KW - Susceptible populations

UR - http://www.scopus.com/inward/record.url?scp=55649087353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55649087353&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2008.05.002

DO - 10.1016/j.taap.2008.05.002

M3 - Article

VL - 233

SP - 76

EP - 80

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 1

ER -